All Insights
Showing 1 - 12 of 298
Life Sciences and Healthcare
EU proposes tailored approach to streamline biosimilar development
New EMA reflection paper signals a step change in biosimilar approval, reducing requirements while maintaining standards
Life Sciences and Healthcare
New regulations signal next step for precision bred plants in England
Government sets out new simplified authorisation process for precision bred organisms
Regulatory and compliance
How is the UK regulatory landscape set to change?
The government is driving a pro-growth agenda, leading to transformative changes in regulatory operations
Life Sciences and Healthcare
EU set to upgrade medtech and diagnostics regulations
Commission-led targeted evaluation and reforms to the EU medical devices regulatory framework are reshaping the sector
Life Sciences and Healthcare
EU regulatory activity is driving comprehensive reforms for pharma in 2025
The European Union's regulatory framework for the pharmaceutical sector is undergoing significant transformations
Commercial
New EU packaging and waste regulation comes into force to promote sustainability
Effective implementation of this advance for the circular economy now depends on national legislation by Member States
Regulatory and compliance
Court of Appeal rules on duty to clarify tender submissions with bidders in UK public procurement
Decision explains when contracting authorities must clarify incomplete or ambiguous information in tender submissions
Life Sciences and Healthcare
The fight against counterfeit medicines in Italy
The Italian legislative decree implementing Regulation (EU) 2016/161 enters into force
Life Sciences and Healthcare
The Future of Cannabis in Germany: What to Expect After the 2025 Elections
The German cannabis industry is transforming rapidly. The introduction of the Cannabis Act (CanG) in April 2024 brought significant changes
Regulatory and compliance
New NPPS sets out 'value for money' message for UK public procurement
Government wants public bodies to use procurement to drive growth, social and economic value, and commercial capability
Life Sciences and Healthcare
Genetic resources, IP and benefits sharing: what changes are ahead internationally?
The WIPO has set out disclosure rules for patent applications as the UN pushes for sharing digital sequence information
Life Sciences and Healthcare
Streamlined reimbursement law looks to boost medicine access in Poland
What can Poland's pharmaceutical industry expect from further reforms due in the second quarter of this year?
